Showing results (331-340 of 376) with videos related to
Sort By:
Pageof 38
HIV Medicine|December 9, 2021
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in EuropeSarah Amele, Anastasia Karachalia Sandri, Alison Rodger, et al.Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 24, 2017
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2022
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized TrialLaura Waters, Lambert Assoumou, Ana González-Cordón, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2023
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 TrialAbiu Sempere, Lambert Assoumou, Ana González-Cordón, et al.Infectious Diseases and Therapy|April 11, 2022
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish CohortRamón Teira, Helena Diaz-Cuervo, Filipa Aragão, et al.AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.Frontiers in Cellular and Infection Microbiology|July 12, 2023
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world studyJosé Ramón Santos, Maria Casadellà, Marc Noguera-Julian, et al.Infectious Diseases (London, England)|July 11, 2020
Linezolid for therapy of Staphylococcus aureus meningitis: a cohort study of 26 patientsVicente Pintado, Rosario Pazos, Manuel Enrique Jiménez-Mejías, et al.Plos One|April 8, 2021
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIVRamón Teira, Helena Diaz-Cuervo, Filipa Aragão, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2005
Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 yearsFrancesc Vidal, Joaquim Peraire, Pere Domingo, et al.Pageof 38